PURMX
Company Details
Status: Public
Employees: 1-10
Location:
1-2-3 Kasumi, Minami-ku, Hiroshima, Hiroshima 734-8553, Japan
Type:
sample
Technology:
sample
sample
sample
sample
sample
sample
About: Creation of optimal nucleic acid medicine for disease treatment with proprietary technology
PURMX's solution is a drug discovery seed of small RNA nucleic acid drugs that fine-tune many target genes and deliver unprecedented therapeutic effects. PURMX already possesses a large amount of functional RNA screening data, which is being further expanded.
The first stage of innovative nucleic acid medicine seeds is MIRX002. MIRX002 is a nucleic acid medicine for malignant pleural mesothelioma. We have completed non-clinical trials and are conducting investigator-initiated clinical trials at Hiroshima University Hospital starting in 2021.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
PURMX | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.